Jo Howard

4.8k total citations · 1 hit paper
103 papers, 2.6k citations indexed

About

Jo Howard is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Jo Howard has authored 103 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Genetics, 66 papers in Hematology and 28 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Jo Howard's work include Hemoglobinopathies and Related Disorders (98 papers), Iron Metabolism and Disorders (46 papers) and Blood groups and transfusion (27 papers). Jo Howard is often cited by papers focused on Hemoglobinopathies and Related Disorders (98 papers), Iron Metabolism and Disorders (46 papers) and Blood groups and transfusion (27 papers). Jo Howard collaborates with scholars based in United Kingdom, United States and Canada. Jo Howard's co-authors include Eugene Oteng‐Ntim, Swee Lay Thein, Ashley P Jones, Sarah J Nevitt, Sally C. Davies, Moji Awogbade, Baba Inusa, A. V. Hoffbrand, H. G. Prentice and Atul Mehta and has published in prestigious journals such as The Lancet, Blood and PLoS ONE.

In The Last Decade

Jo Howard

99 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support

2020 268 citations Stella T. Chou, Mouaz Alsawas et al. Blood Advances profile →

Peers

Countries citing papers authored by Jo Howard

Since Specialization

Citations

This map shows the geographic impact of Jo Howard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jo Howard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jo Howard more than expected).

Fields of papers citing papers by Jo Howard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jo Howard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jo Howard. The network helps show where Jo Howard may publish in the future.

Co-authorship network of co-authors of Jo Howard

This figure shows the co-authorship network connecting the top 25 collaborators of Jo Howard. A scholar is included among the top collaborators of Jo Howard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jo Howard. Jo Howard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Managing sickle cell disease and related complications in pregnancy: results of an international Delphi panel 2024 ·Blood Advances ·Deva Sharma, İlknur Kozanoğlu, Kenneth I. Ataga, Alexandra Benachi, Selim Büyükkurt, Sophie Lanzkron, Hakan Özdoğu, Shivan Pancham, Lydia H. Pecker, Susan Robinson, (unknown), Jo Howard	11
2	Clinical Burden and Health Care Resource Utilization Associated With Managing Sickle Cell Disease With Recurrent Vaso-occlusive Crises in England 2024 ·Clinical Therapeutics ·(unknown), (unknown), Fiona C. Ingleby, Steven Fleming, Sarah C. Conner, Jo Howard, Nanxin Li, Farrukh Shah	0
3	EE287 Healthcare Resource Utilization Among Patients with Transfusion-Dependent Beta-Thalassemia in England 2023 ·Value in Health ·(unknown), (unknown), (unknown), Steven Fleming, (unknown), Jo Howard, Ning Li, Farrukh Shah	2
4	Management of sickle cell disease in pregnancy. A British Society for Haematology Guideline 2021 ·British Journal of Haematology ·Eugene Oteng‐Ntim, Sue Pavord, Richard J. Howard, Susan Robinson, Laura Oakley, Lucy Mackillop, Shivan Pancham, Jo Howard	51
5	American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support breakdown → 2020 ·Blood Advances ·Stella T. Chou, Mouaz Alsawas, Ross M. Fasano, Joshua J. Field, Jeanne E. Hendrickson, Jo Howard, (unknown), Janet L. Kwiatkowski, France Pirenne, Patricia A. Shi, Sean R. Stowell, Swee Lay Thein, Connie M. Westhoff, Trisha E. Wong, Elie A. Akl	268
6	Outcomes following kidney transplantation in patients with sickle cell disease: The impact of automated exchange blood transfusion 2020 ·PLoS ONE ·Joanna Willis, Moji Awogbade, Jo Howard, Cormac Breen, (unknown), Mark Harber, (unknown), Peter Andrews, Jack Galliford, Raj Thuraisingham, (unknown), Sapna Shah, Claire C. Sharpe	11
7	Serial prophylactic exchange blood transfusion in pregnant women with sickle cell disease (TAPS-2): study protocol for a randomised controlled feasibility trial 2020 ·Trials ·Laura Oakley, Moji Awogbade, Sarah Brien, Annette Briley, Maria Chorozoglou, Emma Drašar, Jemma Johns, Elizabeth Rhodes, Vicky Robinson, Paul T. Seed, (unknown), Claire Singh, Paul Telfer, (unknown), (unknown), Jo Howard, Eugene Oteng‐Ntim	13
8	A phase 1/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease 2019 ·Blood ·Jo Howard, Claire Hemmaway, Paul Telfer, D. Mark Layton, John B. Porter, Moji Awogbade, Timothy Mant, Daniel D. Gretler, Kobina Dufu, Athiwat Hutchaleelaha, Mira Patel, (unknown), (unknown), (unknown), Margaret Tonda, Joshua Lehrer‐Graiwer	84
9	Prevention of Morbidity in Sickle Cell Disease Phase II (Improvement of Pain and Quality of Life in Children with Sickle Cell Disease with Auto-adjusting Continuous Positive Airways Pressure: Phase II) (POMS 2b pediatric cohort) 2017 ·Blood ·April Slee, Jamie M. Kawadler, (unknown), (unknown), David C. Rees, (unknown), Jo Howard, Swee Lay Thein, Simon S. Skene, (unknown), (unknown), (unknown), Dawn E. Saunders, Johanna Gavlak, (unknown), (unknown), Christina Liossi, Fenella J. Kirkham, Baba Inusa	4
10	Sickle Cell/β⁰-Thalassemia Associated With the 1393 bp Deletion Can be Associated With a Severe Phenotype 2011 ·Hemoglobin ·Yvonne Daniel, Kim Hill, Baba Inusa, Swee Lay Thein, Jo Howard	4
11	Moving young people with sickle cell disease from paediatric to adult services 2010 ·British Journal of Hospital Medicine ·Jo Howard, (unknown), (unknown), (unknown), Baba Inusa	9
12	a qualitative study of perceptions of using prophylactic penicillin in patients with sickle cell disease 2010 ·Primary Health Care ·(unknown), Jo Howard, (unknown), Veronica Nicky Thomas	4
13	A Prospective Diary Study of Stuttering Priapism in Adolescents and Young Men With Sickle Cell Anemia: Report of an International Randomized Control Trial--The Priapism in Sickle Cell Study 2010 ·Journal of Andrology ·Adebayo Olujohungbe, Adebanji Adeyoju, Anne Yardumian, O.O. Akinyanju, J.A. Morris, (unknown), Y A Aken'Ova, MO Kehinde, Kofi A. Anie, Jo Howard, Ari D. Brooks, (unknown), (unknown)	46
14	Community-acquired Salmonella bacteraemia in patients with sickle-cell disease 1969–2008: A single centre study 2010 ·Scandinavian Journal of Infectious Diseases ·(unknown), Jo Howard, John L. Klein	8
15	Ovarian sickling as a proposed mechanism for premature ovarian failure necessitating ovum donation 2009 ·Menopause international ·(unknown), Jo Howard, Eugene Oteng‐Ntim	15
16	Pain management and quality of life in sickle cell disease 2009 ·Expert Review of Pharmacoeconomics & Outcomes Research ·Jo Howard, Veronica J. Thomas, (unknown)	11
17	The clinical care of adult patients with sickle cell disease 2008 ·British Journal of Hospital Medicine ·Adebayo Olujohungbe, Jo Howard	7
18	The presence of α‐thalassaemia trait blunts the response to hydroxycarbamide in patients with sickle cell disease 2008 ·British Journal of Haematology ·Nisha Vasavda, (unknown), David C. Rees, Sue Height, Jo Howard, Swee Lay Thein	16
19	A nontransfusional perioperative management regimen for patients with sickle cell disease undergoing laparoscopic cholecystectomy 2006 ·Surgical Endoscopy ·Daniel Leff, (unknown), Tushar Agarwal, Sally C. Davies, Jo Howard, Avril Chang	20
20	Mycophenolate mofetil for the treatment of refractory auto‐immune haemolytic anaemia and auto‐immune thrombocytopenia purpura 2002 ·British Journal of Haematology ·Jo Howard, A. V. Hoffbrand, H. G. Prentice, Atul Mehta	122

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact